Statistical inference for cost-effectiveness ratios

Health Economics

Volumn 6, Issue 3, 1997, Pages 229-242

  Laska, Eugene M ^a,b   Meisner, Morris ^a,b   Siegel, Carole ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bonferroni intervals; Clinical trials; Confidence intervals; Cost effectiveness ratios; Fieller intervals; Hypothesis tests

Indexed keywords

COST EFFECTIVENESS ANALYSIS; COVARIANCE; INTERMETHOD COMPARISON; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HEALTH SERVICES RESEARCH; HUMANS; LIKELIHOOD FUNCTIONS; RANDOMIZED CONTROLLED TRIALS; STOCHASTIC PROCESSES;

EID: 0030849288     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199705)6:3<229::AID-HEC268>3.0.CO;2-M     Document Type: Review

References (28)

1. O'Brien, B. J., Drummond, M. F. and Labelle R. J. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care 1994; 32: 150-163.
2. Drummond M. F., Stoddart, G. L. and Torrance, G. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1987.
3. Drummond, M. F. and Davies, L. M. Economic analysis alongside clinical trials: revisiting the methodological issues. International Journal of Technological Assessment of Health Care 1991; 7: 561-573.
4. Drummond, M. F. and O'Brien, B. J. Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes. Health Economics 1992; 2: 205-212.
5. van Hout, B. A. Al, M. J., Gordon, G. S. and Rutten, F. F. H. Costs, effects and CE-ratios alongside a clinical trial. Health Economics 1994; 3: 309-319.
6. Wakker, P. and Klaassen, M. P. Confidence intervals for cost/effectiveness ratios. Health Economics 1995; 4: 373-381.
7. Willan, A. R. and O'Brien, B. J. Confidence Intervals for cost-effectiveness ratios: An application of Fieller's theorem. Health Economics 1996; 5: 297-305.
8. Siegel, C., Laska, E. M. and Meisner, M. Statistical methods for cost-effectiveness analysis. Controlled Clinical Trials 1996; 17: 387-406.
9. Miller, R. G. Simultaneous Statistical Inference. New York: Springer, 1981.
10. Feller, W. An Introduction to Probability Theory and its Applications. 2nd edn, Vol. 1. New York: Wiley, 1957.
11. Heller, E. C. The biological standardization of insulin. Journal of the Royal Statistical Society 1940; 137: 1-53.
12. Fieller, E. C. A fundamental formula in the statistics of biological assay, and some applications. Quarterly Journal of Pharmacy and Pharmacology 1940; 17: 117-123.
13. Fieller, E. C. Some problems in interval estimation. Journal of the Royal Statistical Society, Series B 1954; 16: 175-185.
14. Finney, D. J. Statistical Methods in Biological Assay. New York: Macmillan, 1978.
15. Zerbe, G. O. On Heller's theorem and the general linear model. The American Statistician 1978; 32: 103-105.
16. Volund, A. Multivariate bioassay. Biometrics 1980; 36: 225-236.
17. Zerbe, G. O., Laska, E. M., Meisner, M. and Kushner, H. B. On multivariate confidence regions and simultaneous confidence limits for ratios. Communications in Statistics, Theory and Methods 1982; 11: 2401-2425.
18. Laska, E. M., Kushner, H. B. and Meisner, M. Reader reaction: multivariate bioassay. Biometrics 1985; 41: 547-554.
19. Sacristan, J. A., Day S. J., Navarro, O., Ramos, J. and Hernandez, J. M. Use of confidence intervals and sample size calculations in health economic studies. Annals of Pharmacotherapy 1995; 29: 719-725.
20. Chaudhary, M. A. and Stearns, S. C. Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Statistics in Medicine 1996; 15: 1447-1458.
21. Gardiner, J., Hogan, A., Holmes-Rovner, M., Rovner, D., Griffith, L. and Kupersmith, J. Confidence intervals for cost-effectiveness ratios. Medical Decision Making 1995; 15: 254-263.
22. Fisher, C. J., Slotman, G. J., Opal, S. M., et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Critical Care Medicine 1994; 22: 12-21.
23. Gordon, G. S., Fisher, C. J., Slotman, G. J., et al. Cost-effectiveness of treatment with interleukin-1 receptor antagonist (IL-IRA) in patients with sepsis syndrome. Clinical Research 1992; 40: 254A.
24. Weinstein, M. C. and Stason, W. B. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 1994; 296: 716-721.
25. Kendall, M. G. and Stuart, A. The Advanced Theory of Statistics, 4th edn, Vol. 1. Oxford: Oxford University Press, 1979.
26. Weinstein, M. C., Siegel, J. E., Gold, M. R., et al. Recommendations of the panel on cost effectiveness in health and medicine. Journal of the American Medical Society 1996; 276: 1253-1258.
27. Laska, E. M. and Meisner, M. J. Testing whether an identified treatment is best. Biometrics 1989; 45: 1139-1151.
28. Scheffé, H. Multiple testing versus multiple estimation, improper confidence sets, estimation of direction and ratios. The Annals of Mathematical Statistics 1970; 41: 1-29.